BTKis could inhibit NFκB activation, which suggested that cell death in non-GCB-DLBCL induced by BTKis might correlated with down-regulating NFκB signaling pathway (Fig. 3g, h). This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.